{"pmid":32359188,"title":"Strategies to halt 2019 novel coronavirus (COVID-19) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, China.","text":["Strategies to halt 2019 novel coronavirus (COVID-19) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, China.","During the coronavirus outbreak in China, our center performed 16 organ transplants (10 kidney, 4 liver and 2 lung transplants, from January 24 to March 11, 2020) harvested from deceased donors. Regarding the strategies to prevent infections of COVID-19, we implemented specific measures for the donor and recipient management, as well as prevention of hospital-acquired infections. All 16 organ recipients had a favorable outcome without COVID-19 infection. Our approaches aiming to interrupt the spread of coronavirus within the transplantation wards were successful and allowed us to maintain the transplantation program for deceased liver, kidney and lung recipients.","Am J Transplant","Wang, Yi","Liu, Huirong","Buhler, Leo H","Deng, Shaoping","32359188"],"abstract":["During the coronavirus outbreak in China, our center performed 16 organ transplants (10 kidney, 4 liver and 2 lung transplants, from January 24 to March 11, 2020) harvested from deceased donors. Regarding the strategies to prevent infections of COVID-19, we implemented specific measures for the donor and recipient management, as well as prevention of hospital-acquired infections. All 16 organ recipients had a favorable outcome without COVID-19 infection. Our approaches aiming to interrupt the spread of coronavirus within the transplantation wards were successful and allowed us to maintain the transplantation program for deceased liver, kidney and lung recipients."],"journal":"Am J Transplant","authors":["Wang, Yi","Liu, Huirong","Buhler, Leo H","Deng, Shaoping"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32359188","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/ajt.15972","locations":["China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138495292276737,"score":9.490897,"similar":[{"pmid":32282982,"title":"Early Impact of COVID-19 on Transplant Center Practices and Policies in the United States.","text":["Early Impact of COVID-19 on Transplant Center Practices and Policies in the United States.","COVID-19 is a novel, rapidly-changing pandemic: consequently, evidence-based recommendations in solid organ transplantation (SOT) remain challenging and unclear. To understand the impact on transplant activity across the US, and center-level variation in testing, clinical practice, and policies, we conducted a national survey between March 24-31, 2020 and linked responses to the COVID-19 incidence map. Response rate was a very high 79.3%, reflecting a strong national priority to better understand COVID-19. Complete suspension of live donor kidney transplantation was reported by 71.8% and live donor liver by 67.7%. While complete suspension of deceased donor transplantation was less frequent, some restrictions to deceased donor kidney transplantation were reported by 84.0% and deceased donor liver by 73.3%; more stringent restrictions were associated with higher regional incidence of COVID-19. Shortage of COVID-19 tests was reported by 42.5%. Respondents reported a total of 148 COVID-19 recipients from <1y to >10y post-transplant: 69.6% were kidney recipients, and 25.0% were critically ill. Hydroxychloroquine (HCQ) was used by 78.1% of respondents; azithromycin by 46.9%; tocilizumab by 31.3%, and remdesivir by 25.0%. There is wide heterogeneity in center-level response across the US; ongoing national data collection, expert discussion, and clinical studies are critical to informing evidence-based practices.","Am J Transplant","Boyarsky, Brian J","Chiang, Teresa Po-Yu","Werbel, William A","Durand, Christine M","Avery, Robin K","Getsin, Samantha N","Jackson, Kyle R","Kernodle, Amber B","Van Pilsum Rasmussen, Sarah E","Massie, Allan B","Segev, Dorry L","Garonzik-Wang, Jacqueline M","32282982"],"abstract":["COVID-19 is a novel, rapidly-changing pandemic: consequently, evidence-based recommendations in solid organ transplantation (SOT) remain challenging and unclear. To understand the impact on transplant activity across the US, and center-level variation in testing, clinical practice, and policies, we conducted a national survey between March 24-31, 2020 and linked responses to the COVID-19 incidence map. Response rate was a very high 79.3%, reflecting a strong national priority to better understand COVID-19. Complete suspension of live donor kidney transplantation was reported by 71.8% and live donor liver by 67.7%. While complete suspension of deceased donor transplantation was less frequent, some restrictions to deceased donor kidney transplantation were reported by 84.0% and deceased donor liver by 73.3%; more stringent restrictions were associated with higher regional incidence of COVID-19. Shortage of COVID-19 tests was reported by 42.5%. Respondents reported a total of 148 COVID-19 recipients from <1y to >10y post-transplant: 69.6% were kidney recipients, and 25.0% were critically ill. Hydroxychloroquine (HCQ) was used by 78.1% of respondents; azithromycin by 46.9%; tocilizumab by 31.3%, and remdesivir by 25.0%. There is wide heterogeneity in center-level response across the US; ongoing national data collection, expert discussion, and clinical studies are critical to informing evidence-based practices."],"journal":"Am J Transplant","authors":["Boyarsky, Brian J","Chiang, Teresa Po-Yu","Werbel, William A","Durand, Christine M","Avery, Robin K","Getsin, Samantha N","Jackson, Kyle R","Kernodle, Amber B","Van Pilsum Rasmussen, Sarah E","Massie, Allan B","Segev, Dorry L","Garonzik-Wang, Jacqueline M"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282982","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1111/ajt.15915","keywords":["clinical decision-making","epidemiology","guidelines","infectious agents - viral"],"locations":["US","US","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"e_drugs":["Hydroxychloroquine","remdesivir","tocilizumab","Azithromycin"],"topics":["Prevention"],"weight":1,"_version_":1666138491535228928,"score":372.22028},{"pmid":32476233,"title":"Strategies for Liver Transplantation during the SARS CoV-2 Outbreak Preliminary Experience from a Single Center in France.","text":["Strategies for Liver Transplantation during the SARS CoV-2 Outbreak Preliminary Experience from a Single Center in France.","Liver transplantation during the ongoing SARS-CoV-2 pandemic is challenging given the urgent need to reallocate resources to other areas of patient care. Available guidelines recommend to reorganize transplant care but data on clinical experience in the context of SARS-CoV-2 pandemic are scarce. Thus, we report strategies and preliminary results in liver transplantation during the peak of the SARS-CoV-2 pandemic from a single-center in France. Our strategy to reorganize the transplant program included four main steps: optimization of available resources especially intensive care unit capacity, multidisciplinary risk stratification of liver transplantation candidates on the waiting list, implementation of a systematic SARS-CoV-2 screening strategy prior to transplantation and definition of optimal recipient-donor matching. After implementation of these four steps, we performed 10 successful liver transplantations during the peak of the pandemic with a short median intensive care unit stay (2,5 days), benchmark post-transplant morbidity and no occurrence of SARS-CoV-2 infection during follow-up. From this preliminary experience we conclude that efforts in resource planning, optimal recipient selection and organ allocation strategy are key to maintain a safe liver transplant activity. Transplant centers should be ready to readapt their practices as the pandemic evolves.","Am J Transplant","Muller, Xavier","Tilmans, Gilles","Chenevas-Paule, Quentin","Lebosse, Fanny","Antonini, Teresa","Poinsot, Domitille","Rode, Agnes","Guichon, Celine M","Schmitt, Zoe","Ducerf, Christian","Mohkam, Kayvan","Lesurtel, Mickael","Mabrut, Jean-Yves","32476233"],"abstract":["Liver transplantation during the ongoing SARS-CoV-2 pandemic is challenging given the urgent need to reallocate resources to other areas of patient care. Available guidelines recommend to reorganize transplant care but data on clinical experience in the context of SARS-CoV-2 pandemic are scarce. Thus, we report strategies and preliminary results in liver transplantation during the peak of the SARS-CoV-2 pandemic from a single-center in France. Our strategy to reorganize the transplant program included four main steps: optimization of available resources especially intensive care unit capacity, multidisciplinary risk stratification of liver transplantation candidates on the waiting list, implementation of a systematic SARS-CoV-2 screening strategy prior to transplantation and definition of optimal recipient-donor matching. After implementation of these four steps, we performed 10 successful liver transplantations during the peak of the pandemic with a short median intensive care unit stay (2,5 days), benchmark post-transplant morbidity and no occurrence of SARS-CoV-2 infection during follow-up. From this preliminary experience we conclude that efforts in resource planning, optimal recipient selection and organ allocation strategy are key to maintain a safe liver transplant activity. Transplant centers should be ready to readapt their practices as the pandemic evolves."],"journal":"Am J Transplant","authors":["Muller, Xavier","Tilmans, Gilles","Chenevas-Paule, Quentin","Lebosse, Fanny","Antonini, Teresa","Poinsot, Domitille","Rode, Agnes","Guichon, Celine M","Schmitt, Zoe","Ducerf, Christian","Mohkam, Kayvan","Lesurtel, Mickael","Mabrut, Jean-Yves"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32476233","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/ajt.16082","locations":["France","optimal","optimal","France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1668437834987470848,"score":320.88885},{"pmid":32357275,"title":"Strategies for Prevention and Control of the 2019 Novel Coronavirus Disease in the Department of Kidney Transplantation.","text":["Strategies for Prevention and Control of the 2019 Novel Coronavirus Disease in the Department of Kidney Transplantation.","OBJECTIVE: To summarize measures for prevention and control of the 2019 novel Corona Virus Disease (COVID-19) in the department of kidney transplantation. METHODS: We retrospectively analyzed the clinical data of outpatients and inpatients in the department of kidney transplantation from January 20, 2020 to March 1, 2020, and followed up the in-home kidney transplant recipients and those waiting for kidney transplantation through the Internet platform. Our department had formulated detailed prevention and control measures, mainly including: kidney transplant outpatient management, kidney transplantation ward management, management of kidney transplant surgery, dialysis management of patients waiting for kidney transplantation, personal protection of medical staff, follow-up management of discharged patients after kidney transplantation, etc. RESULTS: During the epidemic period, there were no COVID-19 among 68 outpatient examined kidney transplant recipients, 32 hospitalized kidney transplant recipients, 19 patients waiting for kidney transplantation in hospital and 30 medical staff. There were no COVID-19 in the follow-up of 160 recipients after kidney transplantation and 60 patients waiting for kidney transplantation. CONCLUSION: During the epidemic period, we implemented strict prevention and control measures and adjusted working methods and procedures to ensure the safe and orderly work of the department.","Transpl Int","Li, Yurong","Yang, Ning","Li, Xiaoxiao","Wang, Junpeng","Yan, Tianzhong","32357275"],"abstract":["OBJECTIVE: To summarize measures for prevention and control of the 2019 novel Corona Virus Disease (COVID-19) in the department of kidney transplantation. METHODS: We retrospectively analyzed the clinical data of outpatients and inpatients in the department of kidney transplantation from January 20, 2020 to March 1, 2020, and followed up the in-home kidney transplant recipients and those waiting for kidney transplantation through the Internet platform. Our department had formulated detailed prevention and control measures, mainly including: kidney transplant outpatient management, kidney transplantation ward management, management of kidney transplant surgery, dialysis management of patients waiting for kidney transplantation, personal protection of medical staff, follow-up management of discharged patients after kidney transplantation, etc. RESULTS: During the epidemic period, there were no COVID-19 among 68 outpatient examined kidney transplant recipients, 32 hospitalized kidney transplant recipients, 19 patients waiting for kidney transplantation in hospital and 30 medical staff. There were no COVID-19 in the follow-up of 160 recipients after kidney transplantation and 60 patients waiting for kidney transplantation. CONCLUSION: During the epidemic period, we implemented strict prevention and control measures and adjusted working methods and procedures to ensure the safe and orderly work of the department."],"journal":"Transpl Int","authors":["Li, Yurong","Yang, Ning","Li, Xiaoxiao","Wang, Junpeng","Yan, Tianzhong"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32357275","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/tri.13634","keywords":["2019 novel coronavirus disease","kidney transplant","pneumonia","prevention and control"],"topics":["Prevention"],"weight":1,"_version_":1666138495198953472,"score":315.9375},{"pmid":32243677,"title":"The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs.","text":["The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs.","The spread of Coronavirus Disease 2019 (COVID-19) has already reached a pandemic dimension within a few weeks. Italy has been one of the first countries dealing with the outbreak of COVID-19, and severe measures have been adopted to limit viral transmission. The spread of COVID-19 may have several implications in organ transplant activity that physicians should be aware of. The initial experience gained during the COVID-19 outbreak shows that around 10% of infected patients in Italy need intensive care management to overcome the acute respiratory distress syndrome. Due to the exponential rise of infected patients we are now facing an actual risk of saturation of intensive care unit (ICU) beds. A restriction in the number of ICU beds available for both donors and transplant recipients may unfavorably influence the overall donation activity, and eventually lead to a reduced number of transplants. Preliminary Italian data show that a 25% reduction of procured organs has already occurred during the first 4 weeks of COVID-19 outbreak. This underlines the need to closely monitor what will be further happening in ICUs due to the COVID-19 spread in the attempt to preserve transplant activity, especially in Western countries where deceased donors represent the major organ resource.","Am J Transplant","Angelico, Roberta","Trapani, Silvia","Manzia, Tommaso Maria","Lombardini, Letizia","Tisone, Giuseppe","Cardillo, Massimo","32243677"],"abstract":["The spread of Coronavirus Disease 2019 (COVID-19) has already reached a pandemic dimension within a few weeks. Italy has been one of the first countries dealing with the outbreak of COVID-19, and severe measures have been adopted to limit viral transmission. The spread of COVID-19 may have several implications in organ transplant activity that physicians should be aware of. The initial experience gained during the COVID-19 outbreak shows that around 10% of infected patients in Italy need intensive care management to overcome the acute respiratory distress syndrome. Due to the exponential rise of infected patients we are now facing an actual risk of saturation of intensive care unit (ICU) beds. A restriction in the number of ICU beds available for both donors and transplant recipients may unfavorably influence the overall donation activity, and eventually lead to a reduced number of transplants. Preliminary Italian data show that a 25% reduction of procured organs has already occurred during the first 4 weeks of COVID-19 outbreak. This underlines the need to closely monitor what will be further happening in ICUs due to the COVID-19 spread in the attempt to preserve transplant activity, especially in Western countries where deceased donors represent the major organ resource."],"journal":"Am J Transplant","authors":["Angelico, Roberta","Trapani, Silvia","Manzia, Tommaso Maria","Lombardini, Letizia","Tisone, Giuseppe","Cardillo, Massimo"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243677","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15904","keywords":["critical care/intensive care management","donors and donation: donor-derived infections","editorial/personal viewpoint","epidemiology","health services and outcomes research","infection and infectious agents - viral","infectious disease","organ procurement and allocation","organ procurement organization","organ transplantation in general"],"locations":["Italy","Italy","Italian","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138492107751424,"score":309.07},{"pmid":32330356,"title":"Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States.","text":["Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States.","With the rapidly expanding pandemic of SARS-CoV-2, there is concern that solid organ transplant recipients will be particularly vulnerable to infection and may experience a more severe clinical course. We report four cases of COVID-19 in solid organ transplant recipients including recipients of kidney, liver, lung, and heart transplants. We describe each patient's medical history including transplantation history, their clinical presentation and workup, and their course from diagnosis to either hospital discharge or to improvement in symptoms. These reports demonstrate a range of symptoms, clinical severity, and disease course in solid organ transplant recipients with COVID-19, including two hospitalized patients and two patients managed entirely in the outpatient setting.","Am J Transplant","Kates, Olivia S","Fisher, Cynthia E","Stankiewicz-Karita, Helen C","Shepherd, Amanda K","Church, E Chandler","Kapnadak, Siddhartha G","Lease, Erika D","Riedo, Francis X","Rakita, Robert M","Limaye, Ajit P","32330356"],"abstract":["With the rapidly expanding pandemic of SARS-CoV-2, there is concern that solid organ transplant recipients will be particularly vulnerable to infection and may experience a more severe clinical course. We report four cases of COVID-19 in solid organ transplant recipients including recipients of kidney, liver, lung, and heart transplants. We describe each patient's medical history including transplantation history, their clinical presentation and workup, and their course from diagnosis to either hospital discharge or to improvement in symptoms. These reports demonstrate a range of symptoms, clinical severity, and disease course in solid organ transplant recipients with COVID-19, including two hospitalized patients and two patients managed entirely in the outpatient setting."],"journal":"Am J Transplant","authors":["Kates, Olivia S","Fisher, Cynthia E","Stankiewicz-Karita, Helen C","Shepherd, Amanda K","Church, E Chandler","Kapnadak, Siddhartha G","Lease, Erika D","Riedo, Francis X","Rakita, Robert M","Limaye, Ajit P"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330356","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ajt.15944","locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1666138494612799488,"score":299.86633}]}